Home » Topics » Medical technology

Medical technology
RSS

Clinical Trials Update: December 2007

Jan. 14, 2008

BioWorld Stock Report For Public Biotechnology Companies

Jan. 14, 2008

Financings roundup: ViOptix raises $12.2 million in ‘D’ round of financing

Jan. 14, 2008

Court report: CryoLife rejects liability in suit alleging tissue contamination

Jan. 14, 2008

Alder Gets $40M Series C for Yeast-Based Antibodies

Jan. 14, 2008

By Trista Morrison

Clinic Roundup

Jan. 14, 2008

People in Places

Jan. 14, 2008

Product Briefs

Jan. 14, 2008

Stock Winners and Losers For The Week

Jan. 14, 2008

American Society Of Hematology (ASH) Meeting Clinical Trials News: December 2007

Jan. 14, 2008

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 15, 2026.
ASGCT 2026: Circular RNA, the new beast in gene and cell therapy
BioWorld
Circular RNA (circRNA) is not a new concept, but it is a novel strategy in the field of gene and cell therapy. While mRNA vaccines have revolutionized medicine,...
ASGCT 2026: Uncovering the mechanisms of AAV toxicity
BioWorld
Gene therapies rely on vectors to reach the target tissue where they act, such as adeno-associated viruses (AAVs) or lipid nanoparticles (LNPs), among other...
ASGCT 2026: Directed evolution in gene therapy
BioWorld
Directed evolution has become a central pillar in gene therapy. This engineering strategy enables the generation of more efficient variants of genetic editors and...
Fosun secures rights to Aribio’s AR-1001 in potential $4.7B deal
BioWorld
Shanghai Fosun Pharmaceutical (Group) Co. Ltd. is paying $60 million up front for an option to secure exclusive rights to Aribio Co. Ltd.’s oral phase III-stage...